The Role of Blood Flow Restriction Therapy in Postop Rehabilitation of Foot and Ankle Injuries
NCT ID: NCT05844280
Last Updated: 2024-12-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2026-08-31
2029-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control Group
receiving physical therapy with BFR+NMES devices used at sub-therapeutic levels
BFR+NMES at sub therapeutic level
This means that the BFR tourniquet and the NMES device will be at such low settings as to not create the treatment effect but subject will have the equipments on their thigh during exercise
Treatment Group
receiving physical therapy with BFR+NMES devices used at settings that are deemed by prior studies to be therapeutic
BFR+NMES at therapeutic level
This group will receive therapy with BFR+NMES devices used at settings that are deemed by prior studies to be therapeutic.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
BFR+NMES at therapeutic level
This group will receive therapy with BFR+NMES devices used at settings that are deemed by prior studies to be therapeutic.
BFR+NMES at sub therapeutic level
This means that the BFR tourniquet and the NMES device will be at such low settings as to not create the treatment effect but subject will have the equipments on their thigh during exercise
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* history of significant cardiac disease defined as a recent stent placement in past
* history of peripheral arterial disease
* history of sickle cell disease
* history of coagulopathy
* presenting to surgery \>14 days after injury
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Alabama at Birmingham
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Michael Johnson
Principal Investigator
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB-300009735
Identifier Type: -
Identifier Source: org_study_id